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Pacemaker and implantable cardioverter-deﬁbrillator (ICD)
lead perforations are well described and may cause many
complications. Delayed cardiac perforation (DCP) is a less
recognized complication of device implantation and is
believed to be rare. We present a case of DCP wherein 2
simultaneous ICD lead perforations occurred in the right
ventricle (RV) and were overlooked on chest radiograph
(CXR) and chest computed tomography (CT) images. In
patients with implanted cardiac leads presenting with chest
pain or dyspnea, physicians familiar with typical lead
placement should review the radiology images, and not
simply read the reports, to recognize lead perforations.Case Report
An 86-year-old woman with a history of hypertension,
congestive heart failure (CHF), and prior ICD implantation
presented to the emergency department with severe, stabbing
chest pain radiating to the back. The pain had started 2 hours
earlier while she was sitting and was exacerbated by
inspiration. She denied shortness of breath or cough. Her
blood pressure was 198/64 mm Hg, heart rate 60 beats per
minute, and oxygen saturation 99% on a 2-L nasal canula.
An electrocardiogram showed a left bundle branch block.
A CXR report stated that there were no acute pulmonary
ﬁndings and that an ICD device with intracardiac leads was
present, without mention of lead position (Figures 1 and 2).
The CT report noted a trace right pneumothorax, pneumo-
mediastinum, small subsegmental pulmonary embolism in
the right lower lobe, small right pleural effusion, and
pulmonary nodule at the left lung base. A diagnosis of
pulmonary embolus was made. Treatment with enoxaparin
and warfarin was started. Serial cardiac enzyme results were
negative. The patient’s chest pain improved, and she noKEYWORDS Cardiac lead imaging; Cardiac perforations; Delayed cardiac
perforation; Dual right ventricular lead perforation; Implantable
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).longer had pruritic symptoms. She remained hemodynami-
cally stable on anticoagulants and was discharged 2 days
later on enoxaparin and warfarin.
She was readmitted 2 days later with shortness of breath,
palpitations, and constant, severe, substernal chest pain
radiating to the abdomen. She had new onset atrial ﬁbrilla-
tion (AF) with a heart rate of 200 beats per minute, so an
electrophysiology consultation was obtained.
Chest CT images showed an ICD lead perforating the
apex of the RV, with the tip residing in the left lower lung.
On inspection of the chest CT images by the consulting
electrophysiologist, a second perforated RV ICD lead was
seen extending anteriorly and inferiorly out of the RV. A
retrospective evaluation of the CT scan and CXR taken on
the ﬁrst admission demonstrated that both RV ICD lead
perforations had been present at that time. Interrogation of
the ICD showed that all ventricular tachycardia and ven-
tricular ﬁbrillation detection and therapies were programmed
off and the RV pacing outputs had been programmed to
minimum. Outside records were requested.
Both RV ICD leads had been implanted 3 months prior at
another hospital as an upgrade to a biventricular ICD from a
dual-chamber pacemaker previously implanted for sick sinus
syndrome. The ICD had been implanted because of an
ejection fraction of 35%, symptoms of CHF, and left bundle
branch block with intrinsic QRS of 163 ms. Both RV ICD
leads were active-ﬁxation St. Jude Medical Durata 7122
leads (St. Paul, MN). The ﬁrst RV ICD lead was positioned
in the RV apex. The day after the ICD implantation, the
patient complained of chest pain and the RV threshold was
signiﬁcantly higher. Two days later, a second RV ICD lead
was placed in the RV septum. The ﬁrst RV ICD lead was left
in place with the screw retracted. Four weeks later, the
patient received 6 inappropriate ICD shocks for noise. At that
point, the RV output setting was reduced to minimum and
ventricular tachycardia and ventricular ﬁbrillation therapies
were turned off. A CXR report did not mention lead position.
No other data were available from the records obtained.
After the perforations were diagnosed, the patient refused
removal of the leads and requested a “do not resuscitate”
order. The patient was evaluated by a psychologist and
deemed competent. She was aware of the risk of anti-
coagulation with the presence of perforated leads, but shepen access article under the CC BY-NC-ND license
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Figure 2 Lateral radiograph showing unreported right ventricular implan-
table cardioverter-deﬁbrillator lead perforations.
KEY TEACHING POINTS
 Delayed cardiac lead perforations may present with
various symptoms and complications, including
chest pain, loss of capture, inappropriate
implantable cardioverter-deﬁbrillator shocks,
pneumothorax, or pneumomediastinum.
 Simultaneous delayed cardiac perforations from 2
implantable cardioverter-deﬁbrillator leads can
occur. Risk factors for delayed cardiac perforation
include small-diameter and active-ﬁxation leads.
 Surgical intervention for cardiac lead perforation is
an exceedingly rare necessity. Lead perforation is
rare, and less-invasive modalities, including direct
manual extraction with cardiac surgery backup and
pericardiocentesis, are frequently efﬁcacious.
 Cardiac lead perforations may be missed on chest
radiographs and on computed tomography scans
because of reverberation artifact and acoustic
shadowing from metallic leads. In patients with
implanted cardiac leads presenting with chest pain
or dyspnea, physicians familiar with typical lead
placement should review the radiology images, and
not simply read the reports, to recognize lead
perforations.
Heart Rhythm Case Reports, Vol 0, No 0, Month 20162wished to continue anticoagulation therapy to prevent a
stroke. Initially, the ventricular rate in AF was not controlled,
and she developed recurrent CHF symptoms. She was started
on amiodarone therapy, the AF terminated, and she main-
tained sinus rhythm. After 10 days, she was discharged on
warfarin and enoxaparin.
The patient was readmitted 2 days later with weakness.
The international normalized ratio was 3.9. Despite the
perforations and full anticoagulation, she remained stable.
After repeated conversations, she agreed to undergo removal
of the perforated ICD leads and ICD device. AnticoagulationFigure 1 Chest radiograph showing unreported right ventricular implan-
table cardioverter-deﬁbrillator lead perforations.was discontinued, and the preoperative international normal-
ized ratio was 1.4.
The surgeon performed a left thoracotomy. Both leads
extruded from the RV 4–5 cm beyond the pericardium
(Figure 3). The pericardium was excised around both leads,
and the exit points were secured with 4-0 pledgeted Prolene
sutures (Ethicon, Somerville, NJ). The surgeon noted that the
leads moved freely with each heartbeat but there was no
evidence of blood leakage. Both leads were cut at the site of
exit from the myocardium and removed by applying traction
at the lead end located in the pocket. The remaining 2
pacemaker leads, 1 in the right atrium and 1 in the RV, were
found to be functioning normally and were connected to a
new dual-chamber pacemaker. The left ventricular lead, a St.
Jude Medical Quartet 1458Q, was capped and left in place. It
was not compatible with any biventricular pacemaker. An
epicardial left ventricular lead was not placed, because of
pericardial adhesions. The patient tolerated the procedure
well and was discharged on postoperative day 4.Figure 3 Dual right ventricular implantable cardioverter-deﬁbrillator
leads seen protruding from the myocardium during surgery.
3Nelson et al Dual Right Ventricular Lead PerforationTwo months later, a CXR showed complete resolution of
the pleural effusion, pneumothorax, and pneumomediasti-
num. The patient continued on guideline-directed medical
therapy, and her ejection fraction improved to 65%. Her case
was reclassiﬁed 6 months later as New York Heart Associ-
ation class 1.Discussion
To our knowledge, this is the ﬁrst case of simultaneous
cardiac perforations from 2 ICD leads. A pleural effusion,
pneumothorax, and a pneumomediastinum were caused by
the perforations. Complications of pacemaker and ICD lead
perforations are well described and can occur with both
active ﬁxation and passive lead insertion.1,2 Cardiac perfo-
rations from intracardiac leads can result in pleuritic chest
pain, pericardial effusion, hemothorax, lung perforation
manifested by pneumomediastinum and pneumothorax,
diaphragmatic or chest wall pacing, diaphragm or chest wall
perforation, cardiac tamponade, or death.3–6 Despite being
on anticoagulation therapy, our patient did not develop
noticeable bleeding or pericardial effusion. Not all patients
with lead perforation on anticoagulation are as fortunate. A
late lead perforation previously reported resulted in peri-
cardial effusion and cardiac tamponade.7
Female sex, age480 years, lead location, lead stiffness,
and caliber size are risk factors for cardiac lead perfora-
tion.8,9 DCP, deﬁned as the migration and perforation of
implanted leads 1 month or more after implantation, is a less
well-recognized complication of device implantation and is
believed to be rare.10 Small-diameter, active-ﬁxation leads
were associated with a higher risk of DCP.8 DCP of small-
diameter (r8 F) leads occurred 1.6% of the time, and DCP
of active-ﬁxation leads occurred 1.4% of the time.8 No DCP
occurred with standard diameter (48 F) or passive-ﬁxation
leads.8 Our patient’s perforated ICD leads were both small-
diameter (6.3 F), active-ﬁxation leads.
Lead perforations in the right atrium and RV traditionally
were reported to be 0.1%–0.8% for pacemakers and 0.6%–
5.2% for ICDs.11 There is a large discrepancy in the reported
rates of RV lead perforations, ranging from 0.51% to 6%.2,12
The difference in reported rates may stem from different
deﬁnitions of what represents a lead perforation as inter-
preted on a CXR or CT scan by a radiologist. Reverberation
artifact and acoustic shadowing from metallic leads may
cause cardiac perforations to be missed on CT scans.
Retrospective review of our patient’s records revealed that
the correct diagnosis had been missed on prior CXRs and CT
scans. In a similar reported case, an atrial lead protrusion was
diagnosed 5 years after lead implantation.13 Retrospective
CT scan examination showed that the perforation had been
present 4 years earlier.
Surgical intervention for cardiac lead perforation is an
exceedingly rare necessity. In 1 study of 3815 patients who
received an RV lead implant, only 14 were diagnosed with a
cardiac perforation, of which 1 required surgical removal.14
The remaining leads were successfully removed via directmanual traction with cardiac surgery backup.14 Another
study showed that of 2535 patients who received an ICD,
5 patients presented with cardiac tamponade, of which only 2
required surgical intervention.15 Less-invasive treatment
modalities, including direct manual extraction with cardiac
surgery backup and pericardiocentesis, help explain the low
rate of surgical intervention. Because of our patient’s
advanced age and dual lead perforation, we were not
comfortable with percutaneous removal and chose a surgical
approach.Conclusion
A more cautious approach is warranted when reading a CXR
or chest CT scan in a patient with a history of implanted
cardiac leads presenting with chest pain or dyspnea, to
prevent overlooking cardiac lead perforations. Moreover,
physicians familiar with typical lead placement should
review the radiology images, and not simply read the reports,
to help recognize lead perforations.Acknowledgments
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